Media Thread, page-14797

Hey BirdDog66,
I have a few queries and observations, for the educated Bio posters Here ( I am not Bio educated).

Queries-

Of the companies mentioned in recruiting 750 patients for trials, and skipping FDA requirements in Phase 1 studies.
- How much further down the track are we from them. Years- Months ?
- How long would it take them to get reliable data from 750 patients ?
- Are they a viral treatment such as out CF33 & CF19 ?
- Can they also deliver vaccines' via IV ?

-Thanks in advance for anyone answering- but not politicising these queries !


Observations-

- Should any of the answers take the shine off long awaited data coming in the next six months - Then IMU and their management would need to get their skates on. Should data be sensational, however growing with time. Then produce what you have now, in attracting BP's and potential partners providing revenue and stability.

- On a brighter note, it seems as though our treatment would become a shoe with Standard of Care. Should safety and efficacy show even just OK results, for inoperable cancers and tumors that can no longer be treated, then our virus would surely offer some hope. If not for a cure, but for prolonging life or stabilizing patients.

Conclusion-
There will always be competitors. Whilst we've been patiently and slowly pulling the string back in our bow, before delivering our shot(s) to the market- Whatever new's thats coming, can't come quick enough. But why panic after all the sacrifice and miss our target. Just because a few of our competitors, along way behind us are talking about making a few shots !

-GO IMU!



Not Financial Advice - Opinions Only - DYOR!